Physician Profile
Carlos E. Arce-Lara, M.D.
Unclaimed ProfileAbout Dr. Arce-Lara
Based in Casa Grande, AZ, Carlos E. Arce-Lara, M.D. is listed in the NPI registry under hematology/oncology. Carlos is also listed as specializing in hematology & oncology and medical oncology. Medicare claims data shows Carlos provided 75,895 services to 3,233 patients. The services billed most often include injection, aprepitant, 1 mg, injection, darbepoetin alfa, 1 microgram (non-esrd use), and injection, denosumab, 1 mg. NPI 1326265273 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Education & Training
Specialty
Credentials & Licensing
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (520) 836-9800
- Email not available
Practice Locations
1876 E SABIN DR STE 10
Casa Grande, AZ 85122
Conditions Commonly Evaluated or Treated
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Anemia
- Blood clots
- Breast cancer
- Colon cancer
- Iron-deficiency anemia
- Leukemia
- Lung cancer
- Lymphoma
- Prostate cancer
Advanced Cancers
- Cancer That Has Spread
Blood & Lymph Disorders
- Enlarged spleen
- Swollen Lymph Nodes
Blood Cancers
- Multiple Myeloma
- Myelodysplastic Syndrome
Blood Disorders
- Bleeding Disorders
- Blood Clot in Lung
- Blood Clotting Gene Mutation
- Deep vein thrombosis
- Hemochromatosis
- High Platelet Count
- High White Blood Cell Count
- Low Platelets
- Low White Blood Cell Count
- Thick Blood
- Unexplained Bruising
Blood disorders
- Bone Marrow Scarring
- Hemolytic Anemia in Children
- Pre-Myeloma Protein In Blood
- Vitamin B12 deficiency anemia
Bone & Soft Tissue Cancers
- Bone tumors
- Soft-tissue sarcoma
Digestive Cancers
Endocrine Cancers
Endocrine tumors
- Neuroendocrine Tumors
Gastrointestinal cancer
- Anal cancer
- Appendix cancer
- Bile duct cancer
- Gallbladder cancer
General oncology
- Cancer of unknown primary
Genetic Blood Disorders
- Sickle cell disease
- Thalassemia
Gynecologic cancer
- Vulvar cancer
Gynecologic Cancers
Head & Neck Cancers
- Oral cancer
Head and neck cancer
- Laryngeal cancer
- Oral cavity cancer
Neurologic Cancers
- Brain tumor
Oncologic emergencies
- High calcium from cancer
Ophthalmologic oncology
- Melanoma of the eye
Skin cancer
Skin Cancers
- Melanoma
Urologic Cancers
Procedures & services
Most searched procedures
- Blood transfusion
- Chemotherapy
- Immunotherapy
- Targeted therapy
Biopsies & Diagnostics
- Bone Marrow Biopsy
- Lumbar puncture
- Lymph Node Biopsy
Blood disorder care
- Blood Exchange Transfusion
- Photopheresis
Cancer Therapies
- Hormone Therapy For Cancer
Cancer therapy
- Chemo allergy desensitization
- Oral chemotherapy management
- Radiation oncology consultation
- Spinal chemo injection
Cellular Therapies
- CAR-T Therapy
- Stem Cell Transplant
Consultations
- Cancer Survivorship Care Plan
- Clinical Trial Screening
- Second Opinion For Cancer
Diagnostic testing
- Circulating tumor cell test
Hematology Treatments
- Blood Clot Management
- Plasmapheresis
- PRP Injection
- Therapeutic Blood Draw
Imaging
- PET Scan
Infusions
- Clotting Factor Replacement
- Iron Infusion
- IV fluids
- IVIG Infusion
Interventional oncology
- Radiofrequency ablation
- TACE Chemoembolization
Supportive Cancer Care
- Bone Strengthening Injections For Cancer
- Pain Management For Cancer
- Red Blood Cell Booster Shot
- White Blood Cell Booster Injection
Supportive cancer care
- Cancer nutrition counseling
- Chemo brain treatment
- Cold cap therapy for hair loss
- Fertility Preservation for Teens Before Cancer Treatment
- Hyperbaric oxygen for radiation damage
- Lymphedema Drainage Therapy
- Palliative cancer care
Surgical & Vascular Access
- Chemo port placement
- Chemo port removal
- Draining lung fluid
- Paracentesis
- PICC line placement coordination
Testing & Genetics
- Cancer Genetic Testing
- Cancer Tumor Profiling
- Liquid Biopsy
Vascular access care
- Chemo port check
- Chemo Port Flush And Maintenance
- PICC line dressing change
Procedures Most Often Billed to Medicare
75,895 services · 3,233 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
2,527 | More than most peers in Hematology/Oncology |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Treatment | 96367 |
825 | More than most peers in Hematology/Oncology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
742 | More than most peers in Hematology/Oncology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
635 | More often than most peers in Hematology/Oncology |
| Administration of additional new drug or substance into vein, 1 hour or less | Treatment | 96417 |
258 | More than most peers in Hematology/Oncology |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Treatment | 96368 |
250 | More than most peers in Hematology/Oncology |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
220 | More often than most peers in Hematology/Oncology |
| Injection, aprepitant, 1 mg | Drug given | J0185 |
21,320 | More than most peers in Hematology/Oncology |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
14,450 | As often as other peers in Hematology/Oncology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
7,500 | More often than most peers in Hematology/Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Also at this address 4
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
Trained at Other 8
Other providers in the same specialty who trained at the same institution.
Class of 1999 at Other 8
Providers who graduated from the same medical school in the same year.
More connections — 8 related providers in 1 group
Also performs Insertion of needle into vein for collection of blood sample 8
Providers in AZ who bill this service to Medicare most often.
Common questions
What does Carlos E. Arce-Lara specialize in?
Carlos E. Arce-Lara is a hematology/oncology in Casa Grande, AZ. That is the designation recorded for this NPI in the federal registry.
NPI registry
Where is Carlos E. Arce-Lara located?
Carlos E. Arce-Lara is listed at 1876 E Sabin Dr Ste 10, Casa Grande, AZ 85122. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
What is Carlos E. Arce-Lara's phone number?
The number on file is (520) 836-9800. Contact the office directly to confirm availability and scheduling.
NPI registry
What is the NPI for Carlos E. Arce-Lara?
Carlos E. Arce-Lara's National Provider Identifier is 1326265273. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Where did Carlos E. Arce-Lara train?
Carlos E. Arce-Lara attended Other, graduating in 1999. This comes from the CMS National Downloadable File.
CMS public data
How much experience does Carlos E. Arce-Lara have?
Carlos E. Arce-Lara has 27 years experience. Calculated from a graduation year of 1999, reported in the CMS National Downloadable File.
CMS public data
What does Carlos E. Arce-Lara do most often?
According to Medicare billing data, Carlos E. Arce-Lara performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less and administration of chemotherapy into vein, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Is Carlos E. Arce-Lara's profile verified?
Not yet. This profile is built from public federal data and has not been confirmed by Carlos E. Arce-Lara. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.